Dr Alex Zhavoronkov uses AI to uncover useful molecules This is the fourth feature in a six-part series that is looking at how AI is changing medical research and treatments. Over a video call, Alex Zhavoronkov holds up a small, green, diamond-shaped pill. It has been developed by his company to treat a rare progressive lung disease for which there is no known cause or cure. The new drug has yet to be approved, but in small clinical trials has shown impressive efficacy in treating idiopathic pulmonary fibrosis (IPF). It’s one of a new wave of drugs where artificial intelligence (AI) has been integral to its discovery. "We can’t say we have the first AI discovered and designed molecule approved," says Dr Zhavoronkov, the co-founder and CEO of US-based […]
Original web page at www.bbc.com
